Prognostic Significance of Nomogram and T-Score in Locally Advanced Cervical Cancer Patients Treated with Curative Chemoradiotherapy and Image-Guided Brachytherapy: A Single-Center Retrospective Study
Authors:
- Kamuran IbisKIKamuran Ibis
- Can IlginCICan Ilgin
- Leyla SuncakLSLeyla Suncak
- Canan Koksal AkbasCACanan Koksal Akbas
- Deniz BolukbasDBDeniz Bolukbas
- Mustafa DenizliMDMustafa Denizli
- Abdulmunir AzizyAAAbdulmunir Azizy
- Begum YilmazBYBegum Yilmaz
- Seda Guler OzbenSOSeda Guler Ozben
- Ayca Iribas CelikACAyca Iribas Celik
- Nezihe Seden KucucukNKNezihe Seden Kucucuk
- Inci Kizildag YirginIYInci Kizildag Yirgin
Open Access
- 25 August 2025
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 15 (17) , 2142
Abstract
Objective: To investigate the survival prediction probability of the nomogram from retro-EMBRACE and the T-score in patients with locally advanced cervical cancer (LACC). Materials and Methods: A total of 204 patients with LACC who underwent curative chemoradiotherapy and brachytherapy (BT) between 2010 and 2021 were included in our single-center retrospective study. Clinical records, examinations, and magnetic resonance images (MRI) before and after external beam radiotherapy (EBRT) were retrospectively reviewed to obtain information on age, tumor size, parametrial involvement, ureteral involvement, bladder invasion, uterine involvement, high-risk clinical target volume at the first brachytherapy application, lymph node involvement, vaginal involvement, recurrence, metastasis, and last follow-up. The 5-year overall survival probabilities of the patients were determined by nomogram. T-score was calculated separately at diagnosis (TSD) and brachytherapy (TSBT), and their effects on local recurrence-free survival, disease-free survival, and overall survival were analyzed. Results: The median age was 52 (29–89). The 5-year survival rate of the patients was calculated to be 90.18%. The median nomogram’s survival estimate for 60 months was 70.35% (20.9–87.1). The median TSD and TSBT were 5.5 (1–16) and 1 (0–6), respectively. According to the multivariate Cox regression models, TSD (HR = 1.203, 95% CI 1.021–1.417, p = 0.024) was significantly associated with local recurrence-free survival. Conclusions: This study demonstrated that the nomogram’s predictions for 60-month overall survival are underestimates. Prognosis can be estimated using the TSD, which can be easily obtained with a clinical examination and detailed MRI examination.Keywords
This publication has 37 references indexed in Scilit:
- Recent advances in gynecologic radiation oncologyCancer, 2025
- Construction and Validation of a MRI‑Based Radiomic Nomogram to Predict Overall Survival in Patients with Local Advanced Cervical Cancer: A Multicenter StudyAcademic Radiology, 2024
- Cervical CancerHematology/Oncology Clinics of North America, 2024
- Nomogram Predicting Overall Survival in Patients With Locally Advanced Cervical Cancer Treated With Radiochemotherapy Including Image-Guided Brachytherapy: A Retro-EMBRACE StudyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2021
- Education and training for image-guided adaptive brachytherapy for cervix cancer—The (GEC)-ESTRO/EMBRACE perspectiveBrachytherapy, 2020
- Evaluation of a New Prognostic Tumor Score in Locally Advanced Cervical Cancer Integrating Clinical Examination and Magnetic Resonance ImagingInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2020
- Tumor Shrinkage During Chemoradiation in Locally Advanced Cervical Cancer Patients: Prognostic Significance, and Impact for Image-Guided Adaptive BrachytherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2018
- Trends in the Utilization of Brachytherapy in Cervical Cancer in the United StatesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- International Brachytherapy Practice Patterns: A Survey of the Gynecologic Cancer Intergroup (GCIG)International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Radiotherapy versus Concurrent 5-Day Cisplatin and Radiotherapy in Locally Advanced Cervical CarcinomaStrahlentherapie und Onkologie, 2009